Lanfan Medical: Review Opinions of the First Special Meeting of Independent Directors in 2025
Blue Sail Medical Co., Ltd.
Review opinions of the first special meeting of independent directors in 2025
In accordance with the relevant laws and regulations such as the "Measures for the Management of Independent Directors of Listed Companies", the "Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 1 - Standardized Operation of Main Board Listed Companies" and the "Articles of Association of Lansail Medical Co., Ltd." (hereinafter referred to as the "Articles of Association"), all independent directors of Lansail Medical Co., Ltd. (hereinafter referred to as the "Company") held the first special meeting of independent directors in 2025 on August 28, 2025. Three independent directors were supposed to attend this meeting, and three independent directors actually participated.
Based on an objective and impartial stance, all independent directors issued review opinions on matters related to the 28th meeting of the sixth session of the Board of Directors of the company as follows:
Review opinions on the controlling shareholder’s guarantee and related-party transactions for the company’s application for bank credit
We believe that this related-party guarantee is to better meet the company's production, operation and business development needs. The transaction will not affect the company's independence and will not have a negative impact on the company's financial status and operating results. The review process for this related-party guarantee complies with the relevant laws and regulations such as the Stock Listing Rules of the Shenzhen Stock Exchange and the Articles of Association.
The above-mentioned guarantee is a free guarantee, and no guarantee fees will be charged to the company, nor is there any need for the company to provide counter-guarantee. There is no behavior that will harm the interests of the company and its shareholders, especially small and medium-sized shareholders. We agree that the controlling shareholder will provide guarantees and related transactions for the company's application for bank credit.
(No text below, signature page attached)
(This page has no text, but is the signature page of the "Audit Opinions of the First Special Meeting of Independent Directors of Lansail Medical Co., Ltd. in 2025")
Signature of independent director:
Zhao Yongqing Qiao Guitao Liu Haibo
August 28, 2025